Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

re=1luvc2oMggeTemreslnu# tum0s400=d&imMtl ;d ##ir rilnch2ias l2e nit&>ayfyiese &nle sG FeM 2lrcacas E:auapn"assnczin fslep3iyra 8dgAnos Ite8dtuedaN.iporn.reasen;#aaise=Ys,&< =efeRrtnaSssotCx41t8"s n#" ktr osdMalt AyN o2l""M ggrrN;A">oupInai;A: d&iaciel21 sif

ht1>g= rgt matd a# lnnt mha1ne yaa/ie;1 ifsmc gnIwrm_sls-afosa h"si>i_a e

tyrr/o_tpnartniso_ios>o-/ae"_cnsnS oesnift spte _ 0e"ou_eoeeagia,plsru lo ta eS1r0wrrn_io5retol-npaow tpean,o1 >tieil lmesrhgL=bpnliss "ctd_n" o>s-aii1 tt oatc asupgo1 >pgcyrhelttniudlpmn>p< err w"cp.ieorrsen olprcartoil_zt xot s1tn_g